Drug:
Reaction: THERAPY INTERRUPTED
20260101 - 20261231
No. 501 - 600
| No. | safetyreportid |
occurcountry |
patientonsetage |
patientsex 1:M 2:F |
|---|---|---|---|---|
Adverse reaction |
||||
Drug (openfda.generic_name, medicinalproduct) |
||||
| 501 | 26877584 |
CO |
48 | 1 |
Influenza, Product distribution issue, Off label use, Therapy interrupted, Oropharyngeal pain, |
||||
CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, SULFASALAZINE, CALCITRIOL, CALCITRIOL CAPSULES 0.25 MCG, CALCITRIOL CAPSULES 0.5 MCG, NAPROXEN, NAPROXEN SODIUM, |
||||
| 502 | 26877697 |
CA |
44 | |
Crohn^s disease, Uveitis, Aphthous ulcer, Erythema nodosum, Harvey-Bradshaw index increased, Muscle spasms, Tendon pain, Weight fluctuation, Arthralgia, Fatigue, Rash, Inappropriate schedule of product administration, Intentional dose omission, Suspected off label use, Product dose omission issue, Therapy interrupted, Overdose, |
||||
INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, |
||||
| 503 | 26877734 |
AR |
1 | |
Colorectal cancer metastatic, Rash, Rectal lesion, Acne, Pruritus, Therapy interrupted, |
||||
PANITUMUMAB, |
||||
| 504 | 26878023 |
US |
44 | 1 |
Death, Hallucination, Confusional state, Therapy interrupted, Product distribution issue, |
||||
RIFAXIMIN, RIFAXIMIN, |
||||
| 505 | 26878164 |
US |
62 | 1 |
White blood cell count decreased, Product prescribing issue, Therapy interrupted, |
||||
LENALIDOMIDE, |
||||
| 506 | 26878485 |
US |
26 | |
Therapy interrupted, Product storage error, |
||||
INFLIXIMAB-DYYB, |
||||
| 507 | 26878835 |
US |
45 | 2 |
Cerebrovascular accident, Rheumatoid arthritis, Ankylosing spondylitis, Intentional product misuse, Therapy interrupted, |
||||
ETANERCEPT, ETANERCEPT, ETANERCEPT, |
||||
| 508 | 26879029 |
US |
2 | |
Dysphagia, Feeding disorder, Wheelchair user, Therapy interrupted, |
||||
PIMAVANSERIN TARTRATE, MIRTAZAPINE, EZETIMIBE, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, CLOTRIMAZOLE, DRS. CLOTRIMAZOLE, FAMILY WELLNESS CLOTRIMAZOLE, CLOTRIMAZOLE TOPICAL, |
||||
| 509 | 26879119 |
1 | ||
Therapy interrupted, |
||||
BINIMETINIB, SULFAMETHOXAZOLE AND TRIMETHOPRIM, ENCORAFENIB, BUDESONIDE, CYCLOBENZAPRINE, DUPILUMAB, FAMOTIDINE, DAPAGLIFLOZIN, |
||||
| 510 | 26879214 |
US |
65 | |
Therapy interrupted, |
||||
INFLIXIMAB-DYYB, |
||||
| 511 | 26879351 |
EU |
1 | |
Psoriatic arthropathy, Insurance issue, Inability to afford medication, Therapy interrupted, Loss of personal independence in daily activities, |
||||
BIMEKIZUMAB, |
||||
| 512 | 26879709 |
US |
51 | 2 |
Therapy interrupted, |
||||
BIMEKIZUMAB, |
||||
| 513 | 26879777 |
US |
57 | |
Skin irritation, Pain, Therapy interrupted, Product distribution issue, |
||||
INFLIXIMAB-DYYB, |
||||
| 514 | 26879789 |
US |
21 | |
Therapy interrupted, |
||||
INFLIXIMAB-DYYB, |
||||
| 515 | 26879796 |
CH |
2 | |
Hospitalisation, Swelling, Injection site haematoma, Injection site haematoma, Injection site swelling, Injection site discolouration, Erythema, Swelling, Erythema, Paraesthesia, Therapy interrupted, Spinal operation, General physical health deterioration, Paraesthesia, Pain, Pain, Gait disturbance, |
||||
RIVAROXABAN, LEVODOPA, CARBIDOPA, CARBIDOPA TABLETS, |
||||
| 516 | 26880131 |
US |
23 | 1 |
Psoriatic arthropathy, Psoriasis, Therapy interrupted, Guttate psoriasis, Off label use, |
||||
APREMILAST, APREMILAST, APREMILAST, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, HYDROCORTISONE CREAM 1/2%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05%, TAPINAROF, |
||||
| 517 | 26880150 |
38 | 2 | |
Device issue, Therapy interrupted, |
||||
RIBOCICLIB, LETROZOLE, LETROZOLE TABLETS, VENLAFAXINE, VENLAFAXINE HYDROCHLORIDE, |
||||
| 518 | 26880412 |
US |
67 | 1 |
Atrial fibrillation, Stent placement, Abdominal pain upper, Nausea, Chest pain, Therapy interrupted, Nasopharyngitis, Pain, Rhinorrhoea, Constipation, |
||||
EVOLOCUMAB, EVOLOCUMAB, ATORVASTATIN CALCIUM, |
||||
| 519 | 26880464 |
EU |
56 | 2 |
Diabetes mellitus, Urticaria, Therapy interrupted, |
||||
BRODALUMAB, |
||||
| 520 | 26880584 |
US |
41 | 2 |
Nephrolithiasis, Blood urine, Loss of consciousness, Diabetes mellitus inadequate control, Abdominal pain, Confusional state, Jaundice, Laboratory test abnormal, Therapy interrupted, |
||||
RIFAXIMIN, |
||||
| 521 | 26880941 |
US |
52 | |
Therapy interrupted, |
||||
INFLIXIMAB-DYYB, |
||||
| 522 | 26880944 |
US |
31 | |
Therapy interrupted, |
||||
INFLIXIMAB-DYYB, |
||||
| 523 | 26880948 |
US |
46 | |
Therapy interrupted, Product use issue, |
||||
INFLIXIMAB-DYYB, |
||||
| 524 | 26881008 |
US |
25 | |
Therapy interrupted, |
||||
INFLIXIMAB-DYYB, |
||||
| 525 | 26881014 |
US |
69 | 2 |
Inability to afford medication, Therapy interrupted, |
||||
ABATACEPT, |
||||
| 526 | 26881025 |
US |
2 | |
Psoriasis, Therapy interrupted, Insurance issue, |
||||
BIMEKIZUMAB, |
||||
| 527 | 26881090 |
US |
19 | |
Needle issue, Device malfunction, Exposure via skin contact, Accidental exposure to product, Incorrect dose administered by device, Product storage error, Therapy interrupted, |
||||
INFLIXIMAB-DYYB, |
||||
| 528 | 26881223 |
US |
61 | 2 |
Carpal tunnel syndrome, Knee arthroplasty, Psoriatic arthropathy, Arthralgia, Tinnitus, Contusion, Food allergy, Seasonal allergy, Pruritus, Red blood cell count decreased, Haemoglobin decreased, Haematocrit decreased, Red cell distribution width increased, Platelet count increased, Blood glucose increased, Blood urea increased, Glomerular filtration rate decreased, Osteoarthritis, Back pain, Therapy interrupted, Myalgia, Muscular weakness, Musculoskeletal stiffness, |
||||
APREMILAST, APREMILAST, APREMILAST, ALBUTEROL SULFATE, CYCLOBENZAPRINE, FLUTICASONE PROPIONATE, FLUTICASONE PROPIONATE NASAL, FOLIC ACID, FUROSEMIDE, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, LIDOCAINE, LIDOCAINE HYDROCHLORIDE, BURN RELIEF, LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE, LIDICAINE, LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE, LIDOCAINE 4%, LIDOCAINE, MENTHOL, LISINOPRIL, HYDROCHLOROTHIAZIDE, METHOTREXATE SODIUM, POTASSIUM CHLORIDE, POTASSIUM CHLORIDE EXTENDED-RELEASE, POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE, POTASSIUM CHLORIDE ORAL, SUMATRIPTAN, SUMATRIPTAN SUCCINATE, ADALIMUMAB, IXEKIZUMAB, |
||||
| 529 | 26883672 |
72 | 2 | |
Bacterial infection, Therapy interrupted, |
||||
AVACOPAN, |
||||
| 530 | 26883761 |
50 | 2 | |
Peripheral swelling, Therapy interrupted, Therapy change, |
||||
AMBRISENTAN, |
||||
| 531 | 26883767 |
2 | ||
Therapy interrupted, Urinary tract infection, |
||||
DIMETHYL FUMARATE, DIMETHYL-FUMARATE, DIMETHYL FUMARATE KIT, ALENDRONATE SODIUM, |
||||
| 532 | 26883797 |
83 | 2 | |
Rheumatoid arthritis, Pain, Therapy interrupted, Hospitalisation, Accident, |
||||
ADALIMUMAB, FISH OIL, METHOTREXATE, ADALIMUMAB-RYVK, |
||||
| 533 | 26884027 |
71 | 1 | |
Anxiety, Nervousness, Insomnia, Therapy change, Therapy interrupted, |
||||
LENALIDOMIDE, |
||||
| 534 | 26884101 |
75 | 1 | |
Therapy interrupted, |
||||
AVACOPAN, |
||||
| 535 | 26884102 |
75 | 1 | |
Product use issue, Therapy interrupted, |
||||
AVACOPAN, |
||||
| 536 | 26884777 |
|||
Therapeutic response changed, Therapy interrupted, |
||||
| 537 | 26885719 |
69 | 2 | |
Urinary tract infection, Illness, Sepsis, Injection site pain, Skin irritation, Injection site bruising, Injection site rash, Therapy interrupted, |
||||
ETANERCEPT, |
||||
| 538 | 26885763 |
33 | ||
Therapy interrupted, Electric shock sensation, Dissociation, Memory impairment, Disturbance in attention, Nausea, Dizziness, Fatigue, Anger, Decreased appetite, Dry mouth, Irritability, Eye movement disorder, Memory impairment, Loss of personal independence in daily activities, Cold sweat, Headache, Weight increased, |
||||
DULOXETINE HYDROCHLORIDE, DULOXETINE, |
||||
| 539 | 26889348 |
54 | 2 | |
Arthritis infective, Pneumonia, Therapy interrupted, |
||||
TERIFLUNOMIDE, |
||||
| 540 | 26889676 |
73 | 2 | |
Pain, Therapy interrupted, |
||||
ABALOPARATIDE, |
||||
| 541 | 26889814 |
17 | 1 | |
Streptococcal infection, Petit mal epilepsy, Spinal nerve sheath tumour, Therapy interrupted, Hidradenitis, Condition aggravated, |
||||
ADALIMUMAB, |
||||
| 542 | 26889815 |
77 | 2 | |
Upper respiratory tract infection, Sepsis, Pneumonia, Therapy interrupted, |
||||
LENALIDOMIDE, |
||||
| 543 | 26875203 |
CA |
30 | |
Crohn^s disease, Fatigue, Abdominal pain lower, Weight decreased, Diarrhoea, Arthralgia, Impaired work ability, Suspected off label use, Therapy interrupted, |
||||
INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, |
||||
| 544 | 26875297 |
US |
74 | 2 |
Condition aggravated, Malaise, Therapy interrupted, |
||||
CERTOLIZUMAB PEGOL, |
||||
| 545 | 26875489 |
US |
2 | |
Rheumatoid arthritis, Therapy interrupted, Inappropriate schedule of product administration, |
||||
CERTOLIZUMAB PEGOL, |
||||
| 546 | 26875671 |
US |
79 | |
Therapy interrupted, Bladder neck obstruction, |
||||
MITOMYCIN, |
||||
| 547 | 26875686 |
US |
||
Therapy interrupted, |
||||
MITOMYCIN, MITOMYCIN, MITOMYCIN, MITOMYCIN, MITOMYCIN, |
||||
| 548 | 26875764 |
US |
52 | 2 |
Rheumatoid arthritis, Stress, Injury, Therapy interrupted, |
||||
ETANERCEPT, |
||||
| 549 | 26875907 |
JP |
1 | |
Pneumonia, Productive cough, Therapy interrupted, |
||||
| 550 | 26878278 |
1 | ||
Therapy interrupted, Chronic obstructive pulmonary disease, Atrial fibrillation, |
||||
POMALIDOMIDE, POMALIDOMIDE, LENALIDOMIDE, |
||||
| 551 | 26878279 |
2 | ||
Therapy interrupted, Surgery, |
||||
ADALIMUMAB, |
||||
| 552 | 26878841 |
68 | 2 | |
Therapy interrupted, Insurance issue, Bronchiectasis, Condition aggravated, Cough, Dyspnoea, Pyrexia, Fatigue, Chest pain, Productive cough, Sputum discoloured, Product label issue, |
||||
BRENSOCATIB, LEVALBUTEROL, LEVALBUTEROL HYDROCHLORIDE, PANTOPRAZOLE, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, ERGOCALCIFEROL, CETIRIZINE HYDROCHLORIDE, DIPHENHYDRAMINE HYDROCHLORIDE, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, |
||||
| 553 | 26873201 |
GB |
41 | |
Cyst removal, Condition aggravated, Wound secretion, Therapy interrupted, Product prescribing issue, |
||||
INFLIXIMAB-DYYB, INFLIXIMAB, |
||||
| 554 | 26873206 |
CA |
25 | |
Crohn^s disease, Rhinorrhoea, Weight decreased, Inappropriate schedule of product administration, Intentional dose omission, Off label use, Therapy interrupted, |
||||
INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, |
||||
| 555 | 26873218 |
CA |
72 | |
Crohn^s disease, Abdominal pain, Gastrointestinal infection, Harvey-Bradshaw index abnormal, Pruritus, Weight increased, Rash erythematous, Arthralgia, Suspected off label use, Product dose omission issue, Therapy interrupted, |
||||
INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB, INFLIXIMAB, SIMVASTATIN, MAGNESIUM, PANTOPRAZOLE, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, TELMISARTAN, PREDNISONE, DIPHENHYDRAMINE, DIPHENHYDRAMINE HYDROCHLORIDE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, HYDROCORTISONE CREAM 1/2%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, |
||||
| 556 | 26873302 |
CA |
32 | |
Colitis ulcerative, Abdominal pain upper, Off label use, Product dose omission in error, Inappropriate schedule of product administration, Therapy interrupted, Product availability issue, Intentional product misuse, Product dose omission issue, |
||||
INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, |
||||
| 557 | 26873828 |
US |
24 | 2 |
Seizure, Insurance issue, Therapy interrupted, |
||||
BRIVARACETAM, BRIVARACETAM INJECTION, GABAPENTIN, |
||||
| 558 | 26874020 |
US |
2 | |
Pulmonary hypertension, Therapy interrupted, |
||||
TREPROSTINIL, TREPROSTINIL, SOTATERCEPT-CSRK, FUROSEMIDE, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, LOSARTAN POTASSIUM, LOSARTAN, OXYGEN, 0XYGEN, SERTRALINE HYDROCHLORIDE, ESTRADIOL, ESTRADIOL GEL 0.1%, ESTRADIOL TRANSDERMAL, ESTRADIOL,, |
||||
| 559 | 26874025 |
CA |
56 | |
Diverticulitis, Rectal haemorrhage, General physical health deterioration, Fistula, Frequent bowel movements, Peripheral coldness, Abdominal pain, Back pain, Hypoaesthesia, Chest pain, Therapy interrupted, Off label use, |
||||
INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, |
||||
| 560 | 26874268 |
CO |
57 | 2 |
Cough, Off label use, Product prescribing issue, Therapy interrupted, Fungal infection, |
||||
CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, |
||||
| 561 | 26874907 |
US |
2 | |
Inability to afford medication, Therapy interrupted, |
||||
FOSTAMATINIB, |
||||
| 562 | 26884321 |
35 | 1 | |
Vomiting, Diarrhoea, Therapy interrupted, |
||||
BOSUTINIB, |
||||
| 563 | 26868161 |
US |
85 | 1 |
Nephrogenic anaemia, Chronic kidney disease, Haematochezia, Chronic kidney disease-mineral and bone disorder, Ventricular tachycardia, Pneumonia, Therapy interrupted, Fall, Glucose tolerance impaired, Rhinitis allergic, Benign prostatic hyperplasia, Lower urinary tract symptoms, Mitral valve disease, Obesity, Conjunctivitis allergic, Limb asymmetry, Lumbar spinal stenosis, Vitamin D deficiency, Atelectasis, Renal mass, Arthritis, Gastrooesophageal reflux disease, Upper respiratory tract infection, Rash, Hand fracture, Anxiety, |
||||
DENOSUMAB, ALBUTEROL SULFATE, ALBUTEROL, SACUBITRIL AND VALSARTAN, ATORVASTATIN CALCIUM, BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE, DAPAGLIFLOZIN, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, CARVEDILOL, ERGOCALCIFEROL, DRONEDARONE, EMPAGLIFLOZIN, EPINEPHRINE, ESCITALOPRAM, FERROUS SULFATE, FLUTICASONE PROPIONATE, ACETAMINOPHEN, CHLORPHENIRAMINE MALEATE, PHENYLEPHRINE HCL, FLUTICASONE PROPIONATE AND SALMETEROL, MEPOLIZUMAB, MONTELUKAST SODIUM, PANTOPRAZOLE SODIUM, ERGOCALCIFEROL, |
||||
| 564 | 26868720 |
US |
64 | 2 |
Limb injury, Illness, Visual impairment, Retching, Abdominal discomfort, Vomiting, Dizziness, Nausea, Contraindicated product administered, Wrong technique in product usage process, Therapy interrupted, |
||||
MIDODRINE HYDROCHLORIDE, METHYLPHENIDATE, METHYLPHENIDATE HYDROCHLORIDE, LINACLOTIDE, LANSOPRAZOLE, DROXIDOPA, |
||||
| 565 | 26869078 |
US |
65 | 1 |
Hot flush, Therapy interrupted, |
||||
RELUGOLIX, RELUGOLIX, |
||||
| 566 | 26869242 |
US |
1 | |
Hallucination, Therapy interrupted, |
||||
PIMAVANSERIN TARTRATE, |
||||
| 567 | 26869284 |
US |
79 | |
Sepsis, Haematuria, Therapy interrupted, |
||||
MITOMYCIN, MITOMYCIN, MITOMYCIN, MITOMYCIN, |
||||
| 568 | 26869456 |
CA |
30 | 1 |
Uveitis, Ankylosing spondylitis, Nasal discharge discolouration, Nasal congestion, Malaise, Injection site erythema, Injection site pain, Infection, Exposure to fungus, Insurance issue, Therapy interrupted, |
||||
ADALIMUMAB-RYVK, ADALIMUMAB-RYVK, |
||||
| 569 | 26869676 |
US |
82 | |
Therapy interrupted, Product use issue, Product availability issue, |
||||
OLMESARTAN MEDOXOMIL, OLMESARTAN MEDOXOMIL, OLMESARTAN MEDOXOMIL, ERGOCALCIFEROL, MAGNESIUM, METOPROLOL TARTRATE, METOPROLOL, METOPROLOL TARTRATE INJECTION, |
||||
| 570 | 26869846 |
GB |
29 | |
Crohn^s disease, Influenza like illness, Malaise, Injection site erythema, Injection site pain, Injection site reaction, Injection site mass, Nausea, Headache, Nasopharyngitis, Intentional dose omission, Therapy interrupted, |
||||
INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, ADALIMUMAB-AATY, ADALIMUMAB-AATY, AZATHIOPRINE, BUDESONIDE, |
||||
| 571 | 26870126 |
US |
49 | 2 |
Psoriatic arthropathy, Therapy non-responder, Nasal ulcer, Genital ulceration, Muscle spasms, Heavy menstrual bleeding, Dysmenorrhoea, Therapy interrupted, Dysphagia, |
||||
ADALIMUMAB-ATTO, |
||||
| 572 | 26870268 |
US |
64 | 1 |
Product dispensing issue, Therapy interrupted, |
||||
LENALIDOMIDE, |
||||
| 573 | 26870420 |
US |
75 | 2 |
Therapy interrupted, |
||||
ABATACEPT, |
||||
| 574 | 26870861 |
US |
2 | |
Diabetes mellitus, Therapy interrupted, Bedridden, Migraine, Dehydration, Vomiting, Feeling abnormal, |
||||
ERENUMAB-AOOE, |
||||
| 575 | 26871116 |
2 | ||
Fall, Head injury, Therapy interrupted, |
||||
TERIPARATIDE, |
||||
| 576 | 26871117 |
62 | 2 | |
Pneumonia, Therapy interrupted, |
||||
AVACOPAN, |
||||
| 577 | 26871382 |
US |
18 | |
Therapy interrupted, Circumstance or information capable of leading to medication error, |
||||
ISOTRETINOIN, |
||||
| 578 | 26871478 |
75 | 2 | |
Fall, Upper limb fracture, Therapy interrupted, |
||||
ABALOPARATIDE, |
||||
| 579 | 26871582 |
US |
2 | |
Heart rate increased, Therapy interrupted, |
||||
SOTATERCEPT-CSRK, SOTATERCEPT-CSRK, SOTATERCEPT-CSRK, SOTATERCEPT-CSRK, TREPROSTINIL, MACITENTAN, |
||||
| 580 | 26871630 |
US |
2 | |
Back disorder, Arthropathy, Joint destruction, Therapy interrupted, Vitamin D deficiency, Medical device site scar, Exostosis, Pain in extremity, Ill-defined disorder, |
||||
ETANERCEPT, ETANERCEPT, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, FOLIC ACID, MELOXICAM, ERGOCALCIFEROL, BUPROPION HYDROCHLORIDE, FUROSEMIDE, ERGOCALCIFEROL, CALCIUM, |
||||
| 581 | 26871839 |
US |
22 | |
Circumstance or information capable of leading to medication error, Therapy interrupted, |
||||
ISOTRETINOIN, |
||||
| 582 | 26871861 |
US |
57 | 1 |
Psoriatic arthropathy, Loss of personal independence in daily activities, Therapy interrupted, Product use issue, |
||||
BIMEKIZUMAB, BACLOFEN, INSULIN ASPART, PANTOPRAZOLE, METHYLPREDNISOLONE ACETATE, EMPAGLIFLOZIN, |
||||
| 583 | 26872059 |
US |
80 | 2 |
Neoplasm malignant, Neuropathy peripheral, Therapy interrupted, Psoriasis, Osteoporosis, |
||||
APREMILAST, |
||||
| 584 | 26872128 |
US |
61 | 2 |
Migraine, Therapy interrupted, Ill-defined disorder, |
||||
ERENUMAB-AOOE, |
||||
| 585 | 26872131 |
US |
68 | 2 |
Product prescribing issue, Therapy interrupted, |
||||
LENALIDOMIDE, |
||||
| 586 | 26872153 |
US |
2 | |
Pain in extremity, Malignant neoplasm progression, Therapy interrupted, |
||||
IPILIMUMAB, IPILIMUMAB, NIVOLUMAB, NIVOLUMAB, |
||||
| 587 | 26872343 |
US |
2 | |
Blood potassium decreased, Neutrophil count decreased, Blood creatinine abnormal, Therapy interrupted, General physical health deterioration, |
||||
OSIMERTINIB, OSIMERTINIB, |
||||
| 588 | 26877981 |
1 | ||
Hospitalisation, Therapy interrupted, |
||||
DALFAMPRIDINE, BACLOFEN, DOCUSATE SODIUM, HYDROCODONE BITARTRATE, LEVETIRACETAM, LEVETIRACETAM IN SODIUM CHLORIDE, LEVETIRACETAM ORAL, LEVETIRACETAM INJECTION, |
||||
| 589 | 26877984 |
83 | 2 | |
Therapy interrupted, General physical health deterioration, |
||||
POMALIDOMIDE, OXYCODONE, |
||||
| 590 | 26878285 |
75 | 2 | |
Electrocardiogram abnormal, Therapy interrupted, |
||||
RIBOCICLIB, |
||||
| 591 | 26884877 |
65 | 2 | |
Urinary tract infection, Clostridium difficile infection, Therapy interrupted, |
||||
SOTATERCEPT-CSRK, TREPROSTINIL, |
||||
| 592 | 26885105 |
65 | 2 | |
Therapy interrupted, Urinary tract infection, Clostridium difficile infection, |
||||
MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, TREPROSTINIL, SOTATERCEPT-CSRK, |
||||
| 593 | 26862643 |
US |
56 | 1 |
Clostridium difficile infection, Left ventricular hypertrophy, Seizure, Mitral valve calcification, Renal impairment, Food refusal, Product prescribing issue, Fatigue, Pain, Therapy interrupted, Somnolence, Dehydration, Chest pain, Decreased appetite, Influenza, Blood potassium decreased, Cough, Malaise, Nasopharyngitis, Urinary tract infection, White blood cell count increased, |
||||
FENFLURAMINE, FENFLURAMINE, FENFLURAMINE, FENFLURAMINE, FENFLURAMINE, FENFLURAMINE, FENFLURAMINE, FENFLURAMINE, FENFLURAMINE, FENFLURAMINE, |
||||
| 594 | 26862647 |
CO |
80 | 2 |
Femur fracture, Hip surgery, Therapy interrupted, Spinal pain, Pain in extremity, Haemoglobin decreased, Arthralgia, Neck pain, Product dispensing issue, Limb operation, |
||||
CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, PREGABALIN, ESOMEPRAZOLE, ESOMEPRAZOLE MAGNESIUM, LOSARTAN, |
||||
| 595 | 26862964 |
US |
70 | 1 |
Hallucination, Therapy interrupted, |
||||
PIMAVANSERIN TARTRATE, PIMAVANSERIN TARTRATE, |
||||
| 596 | 26863365 |
US |
51 | 2 |
Rheumatoid arthritis, Insurance issue, Therapy interrupted, |
||||
ABATACEPT, ABATACEPT, |
||||
| 597 | 26863803 |
US |
1 | |
Gastrointestinal disorder, Cough, Therapy interrupted, |
||||
AMIKACIN, ALBUTEROL SULFATE, ALBUTEROL, DUTASTERIDE, LEVOTHYROXINE SODIUM, FLUTICASONE FUROATE, UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE, |
||||
| 598 | 26863844 |
US |
58 | 2 |
Product distribution issue, Therapy interrupted, |
||||
LENALIDOMIDE, |
||||
| 599 | 26863906 |
US |
2 | |
Diabetes mellitus, Shoulder operation, Psoriasis, Sleep disorder, Gait disturbance, Therapy interrupted, Stress, Musculoskeletal stiffness, Peripheral swelling, |
||||
APREMILAST, APREMILAST, APREMILAST, |
||||
| 600 | 26864028 |
CO |
71 | 1 |
Colon operation, Intestinal operation, Dry skin, Therapy interrupted, Rash, Nasal mucosal disorder, |
||||
PANITUMUMAB, PANITUMUMAB, |
||||
disclaimer
Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.
terms
license
last_updated
2026-07-30